Risk factors for breast cancer.

Breast cancer is multifaceted, and multiple risk factors most likely contribute to each case of the disease. Through further elucidation of highly penetrant autosomal dominant mutations and, perhaps more importantly, weaker polygenic influences, rational therapies to treat or prevent malignancy may develop. Determining the nature and sequence of genetic changes in premalignant breast tissue may offer the greatest opportunity to alter the process of breast cancer development. Perhaps the most difficult challenge is to understand the environmental risk factors that predispose to breast cancer. Although endogenous factors such as hormonal influence on breast cancer risk have been established, this information has not greatly affected our ability to prevent or significantly reduce the risk of disease. National and regional collaborative efforts are needed to fund research directed at defining how the environment and lifestyle factors affect the risk of cancer development.

[1]  A. LaCroix,et al.  Bone mineral density and breast cancer risk in postmenopausal women. , 2001, Journal of clinical epidemiology.

[2]  D E Goldgar,et al.  Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.

[3]  G. Berglund,et al.  Smoking associated with hormone receptor negative breast cancer , 2001, International journal of cancer.

[4]  T. Sarkola,et al.  Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women. , 1999, Alcoholism, clinical and experimental research.

[5]  T. Sellers,et al.  Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. , 1999, JAMA.

[6]  D J Schaid,et al.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.

[7]  A. Mes-Masson,et al.  Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. , 1998, American journal of human genetics.

[8]  Ross,et al.  RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin , 2000, Journal of the National Cancer Institute.

[9]  A. Chetrit,et al.  Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. , 1999, Fertility and sterility.

[10]  J. Ranstam,et al.  Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P. Newcomb,et al.  A record-based evaluation of induced abortion and breast cancer risk (United States) , 2000, Cancer Causes & Control.

[12]  S. Gardner,et al.  New Recommendations from the 1999 American College of Cardiology/American Heart Association Acute Myocardial Infarction Guidelines , 2001, The Annals of pharmacotherapy.

[13]  F. Berrino,et al.  Alcohol consumption and total estradiol in premenopausal women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  J. Struewing,et al.  Population-based study of risk of breast cancer in carriers of BRCA2 mutation , 1998, The Lancet.

[15]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[16]  K Offit,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.

[17]  D. Torgerson,et al.  Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. , 2001, JAMA.

[18]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.

[19]  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. , 2000 .

[20]  S. Thacker,et al.  A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer , 1991 .

[21]  D. Bentley,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.

[22]  Postmenopausal hormone therapy and mortality. , 1997 .

[23]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .

[24]  H. Adami,et al.  Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.

[25]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[26]  E. Vittinghoff,et al.  Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. , 2000, Journal of the American Medical Association (JAMA).

[27]  N. Cook,et al.  Physical activity and breast cancer risk: the Women's Health Study (United States) , 2001, Cancer Causes & Control.

[28]  E. Lower,et al.  The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer , 1999, Breast Cancer Research and Treatment.

[29]  J. Thalabard,et al.  Breastfeeding and risk of breast cancer: a metaanalysis of published studies. , 2000, Human reproduction update.

[30]  Yonghong Xiao,et al.  Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.

[31]  P. Boyle,et al.  Lactation and breast cancer risk: a case–control study in Connecticut , 2001, British Journal of Cancer.

[32]  C. Matthews,et al.  Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study , 2001, British Journal of Cancer.

[33]  D. Reboussin,et al.  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. , 2000, The New England journal of medicine.

[34]  Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. , 2001 .

[35]  E. Mariman,et al.  Localization of the gene for Cowden disease to chromosome 10q22–23 , 1996, Nature Genetics.

[36]  Anthony Gamst,et al.  Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .

[37]  C. Amos,et al.  Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p. , 1997, Cancer research.

[38]  O. Olopade,et al.  Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2 , 1999, The Lancet.

[39]  D. Drachman,et al.  Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. , 2001, Archives of neurology.

[40]  F. Speizer,et al.  Alcohol and breast cancer in women: a pooled analysis of cohort studies. , 1998, JAMA.

[41]  P. Tonin,et al.  The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. , 1996, American journal of human genetics.

[42]  K. Heimdal,et al.  Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.

[43]  S. Shapiro,et al.  Induced and spontaneous abortion in relation to risk of breast cancer (United States) , 1997, Cancer Causes & Control.

[44]  W. Dupont,et al.  Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[45]  P. Porter,et al.  Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.

[46]  K M Kuntz,et al.  Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. , 1997, The New England journal of medicine.

[47]  P. Schlag,et al.  Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families , 1997, Oncogene.

[48]  J. Klijn,et al.  Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 , 1998, The Lancet.

[49]  F. Couch,et al.  BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.

[50]  T. Lash,et al.  Alcohol Drinking and Risk of Breast Cancer , 2000, The breast journal.

[51]  J. Kaprio,et al.  Stress of daily activities and risk of breast cancer: A prospective cohort study in Finland , 2001, International journal of cancer.

[52]  W. Willett,et al.  Fracture history and risk of breast and endometrial cancer. , 2001, American journal of epidemiology.

[53]  C. la Vecchia,et al.  Fertility treatment and risk of breast cancer. , 1996, Human reproduction.

[54]  E D Brown,et al.  Serum hormones and the alcohol-breast cancer association in postmenopausal women. , 2001, Journal of the National Cancer Institute.

[55]  S. Cummings,et al.  Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). , 2001, The American journal of medicine.

[56]  C. Lowe,et al.  Age at first birth and breast cancer risk. , 1970, Bulletin of the World Health Organization.

[57]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[58]  J. Olsen,et al.  Induced abortion and the risk of breast cancer. , 1997, The New England journal of medicine.

[59]  B. Weber,et al.  Assessing the risk of breast cancer. , 2000, The New England journal of medicine.

[60]  M. Thun,et al.  Tubal sterilization and risk of breast cancer mortality in US women , 2001, Cancer Causes & Control.

[61]  J. Eyfjörd,et al.  Study of a single BRCA2 mutation with high carrier frequency in a small population. , 1997, American journal of human genetics.

[62]  K Offit,et al.  BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. , 1997, JAMA.

[63]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[64]  G M Lenoir,et al.  Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.

[65]  S. Self,et al.  Risk of breast cancer in a cohort of infertile women. , 1996, Gynecologic oncology.

[66]  D. Grabrick,et al.  Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[67]  E. Nabel Coronary heart disease in women--an ounce of prevention. , 2000, The New England journal of medicine.

[68]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[69]  W. Zheng,et al.  Abortion history and breast cancer risk: Results from the Shanghai breast cancer study , 2001, International journal of cancer.

[70]  M. Melbye,et al.  Age at Any Birth Is Associated with Breast Cancer Risk , 2001, Epidemiology.

[71]  A. Venn,et al.  Breast and ovarian cancer incidence after infertility and in vitro fertilisation , 1995, The Lancet.

[72]  B. Macmahon Reproduction and cancer of the breast , 1993 .

[73]  E. Negri,et al.  Hysterectomy, Oophorectomy in Premenopause, and Risk of Breast Cancer , 1997, Obstetrics and gynecology.

[74]  L. Cupples,et al.  Alcohol consumption and risk of breast cancer: the Framingham Study revisited. , 1999, American journal of epidemiology.

[75]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[76]  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000 .

[77]  M. Skolnick,et al.  Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .

[78]  S Hulley,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[79]  S. Haslam,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Hormone Replacement Therapy with Estrogen or Estrogen plus Medroxyprogesterone Acetate Is Associated with Increased Epithelial Proliferation , 2022 .

[80]  D. Page,et al.  Relation between component parts of fibrocystic disease complex and breast cancer. , 1978, Journal of the National Cancer Institute.

[81]  J L Kelsey,et al.  Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.

[82]  N. Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .

[83]  R. Ross,et al.  RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin , 2000, Journal of the National Cancer Institute.

[84]  M. Longnecker,et al.  Age at any full-term pregnancy and breast cancer risk. , 2000, American journal of epidemiology.

[85]  S. Love,et al.  Fibrocystic Disease of the Breast — A Nondisease? , 1982 .

[86]  O. Olopade,et al.  Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.

[87]  G A Colditz,et al.  A prospective study of folate intake and the risk of breast cancer. , 1999, JAMA.

[88]  G. Colditz,et al.  Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. , 2000, American journal of epidemiology.